Significance of 12S toxin of Clostridium botulinum type E
- PMID: 4977983
- PMCID: PMC315311
- DOI: 10.1128/jb.98.3.1173-1178.1969
Significance of 12S toxin of Clostridium botulinum type E
Abstract
The pathogenesis of type E botulism is discussed as an aspect of the physicochemical and biological properties of 12S toxins (prototoxin and trypsin-activated 12S toxin) and the Ealpha and Ebeta components of each 12S toxin. A molecular weight of 350,000 was determined for each 12S toxin and 150,000 for Ealpha and Ebeta. Owing to the structure comprising the subunits Ealpha and Ebeta, 12S toxins are much more stable than Ealpha at low pH values and high temperatures. Such was also the case with type A 19S toxin and its alpha component. The Ealpha component alone accounts for the total toxicity of type E toxin. The toxic substance detected in the blood of the animals administered 12S toxins orally or parenterally was identified as Ealpha from the molecular size and the chromatographic pattern. Prototoxin escaping from detoxification in the stomach owing to the subunit structure may undergo dissociation in the intestine to release the Ealpha component. After absorption, the activated Ealpha appeared in the circulating blood without any further signs of dissociation or enzymatic digestion.
Similar articles
-
Purification and some properties of Clostridium botulinum type-E toxin.Biochim Biophys Acta. 1968 Oct 21;168(2):207-17. doi: 10.1016/0005-2795(68)90144-x. Biochim Biophys Acta. 1968. PMID: 4972262 No abstract available.
-
Studies of the serum therapy of type E botulism. 3.Jpn J Med Sci Biol. 1970 Jun;23(3):177-91. doi: 10.7883/yoken1952.23.177. Jpn J Med Sci Biol. 1970. PMID: 4989998 No abstract available.
-
Experimental studies on the serum therapy of type E botulism: the relationship between the amount of toxin in the blood and the effect of antitoxic serum.Jpn J Med Sci Biol. 1970 Oct;23(5):344-7. Jpn J Med Sci Biol. 1970. PMID: 4993667 No abstract available.
-
Botulism: cause, effects, diagnosis, clinical and laboratory identification, and treatment modalities.Disaster Med Public Health Prep. 2007 Nov;1(2):122-34. doi: 10.1097/DMP.0b013e318158c5fd. Disaster Med Public Health Prep. 2007. PMID: 18388640 Review.
-
Structure, Function and Evolution of Clostridium botulinum C2 and C3 Toxins: Insight to Poultry and Veterinary Vaccines.Curr Protein Pept Sci. 2017;18(5):412-424. doi: 10.2174/1389203717666161201203311. Curr Protein Pept Sci. 2017. PMID: 27915984 Review.
Cited by
-
Binding of Clostridium botulinum neurotoxin to the presynaptic membrane in the central nervous system.J Cell Biol. 1979 Apr;81(1):43-9. doi: 10.1083/jcb.81.1.43. J Cell Biol. 1979. PMID: 383721 Free PMC article.
-
Crystallization and preliminary X-ray analysis of the Clostridium botulinum type D nontoxic nonhaemagglutinin.Acta Crystallogr Sect F Struct Biol Cryst Commun. 2012 Feb 1;68(Pt 2):227-30. doi: 10.1107/S174430911105603X. Epub 2012 Jan 27. Acta Crystallogr Sect F Struct Biol Cryst Commun. 2012. PMID: 22298006 Free PMC article.
-
Purification and properties of Clostridium botulinum type F toxin.Appl Microbiol. 1975 May;29(5):598-603. doi: 10.1128/am.29.5.598-603.1975. Appl Microbiol. 1975. PMID: 807160 Free PMC article.
-
Evaluation of type A botulinal toxin assays that use antitoxin to crystalline toxin.Appl Microbiol. 1974 Feb;27(2):333-6. doi: 10.1128/am.27.2.333-336.1974. Appl Microbiol. 1974. PMID: 4856714 Free PMC article.
-
Detection of type A, B, E, and F Clostridium botulinum neurotoxins in foods by using an amplified enzyme-linked immunosorbent assay with digoxigenin-labeled antibodies.Appl Environ Microbiol. 2006 Feb;72(2):1231-8. doi: 10.1128/AEM.72.2.1231-1238.2006. Appl Environ Microbiol. 2006. PMID: 16461671 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources